Julie Smith's Net Worth

$1.48 Million

Estimate Recalculated Jul 3, 2024 03:18PM EST

Who is Julie Smith?

Julie Smith has an estimated net worth of $1.48 Million. This is based on reported shares across multiple companies, which include EXELIXIS, INC., Stoke Therapeutics, Inc., Audentes Therapeutics, Inc., and Raptor Pharmaceutical Corp.

SEC CIK

Julie Smith's CIK is 0001557928

Past Insider Trading and Trends

2016 was Julie Smith's most active year for acquiring shares with 4 total transactions. Julie Smith's most active month to acquire stocks was the month of April. 2016 was Julie Smith's most active year for disposing of shares, totalling 5 transactions. Julie Smith's most active month to dispose stocks was the month of September. 2014 saw Julie Smith paying a total of $199,996.50 for 320,015 shares, this is the most they've acquired in one year. In 2016 Julie Smith cashed out on 677,583 shares for a total of $989,442.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

EXELIXIS, INC. (EXEL) Snapshot price: $21.16

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+183.93%
10.02K
15.46K
May 31
Form 4
-83.36%
-27.28K
$21.12
-$576,153.60
5.45K
May 21
Form 4
0
0
Jun 1
Form 4
0
0
May 26
Form 4
+100.75%
16.42K
32.73K
May 27
Form 4
+2,036.44%
15.54K
16.3K
May 21
Form 4
0
0
May 23
Form 4
0
0
May 24
Form 4
0
0
May 25
Form 4
0
0
Feb 23
Form 4
763
763
Sep 22
Form 3
0
0
No matching records found

Stoke Therapeutics, Inc. (STOK) Snapshot price: $4.38

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Jun 5
Form 4
0
0
Jun 13
Form 4
0
0
Jun 7
Form 4
0
0
Jun 8
Form 4
0
0
Jun 3
Form 3
0
0
No matching records found

Audentes Therapeutics, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Jan 15
Form 4
0
0
Feb 6
Form 4
0
0
Jun 8
Form 4
0
0
Oct 8
Form 4
0
0
Jan 1
Form 3
0
0
No matching records found

Raptor Pharmaceutical Corp No price found

President and CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-109.94K
$9.00
-$989,442.00
0
Oct 24 - Oct 25
Form 4
+169.11%
64.18K
102.13K
Feb 9
Form 4
0
0
Jan 15
Form 4
37.95K
$5.27
$199,996.50
37.95K
Dec 3
Form 4
0
0
Jul 29
Form 4
0
0
Feb 7
Form 4
0
0
Sep 10
Form 3
0
0
No matching records found